(Q37132724)

18 August 2017

1 reference

title

Sleep disturbances in patients with parkinsonism (English)

1 reference

18 August 2017

0 references

1 reference

Isabelle Arnulf

3

0 references

Marie Vidailhet

series ordinal

2

object named as

Marie Vidailhet

1 reference

18 August 2017

Valérie Cochen De Cock

series ordinal

1

1 reference

18 August 2017

8 April 2008

1 reference

Nature Clinical Practice Neurology

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

5

1 reference

18 August 2017

254-266

1 reference

Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls.

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Improvement of sleep architecture in PD with subthalamic nucleus stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Daytime sleepiness and other sleep disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Development of daytime somnolence over time in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Parkinson's disease and sleepiness: an integral part of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

REM sleep behavior disorders in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

A community-based study of sleep disorders in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Sleep disorders and their determinants in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Sleep and quantitative EEG in patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Head tremor after a remission of spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Effects of bilateral subthalamic stimulation on sleep in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Exploring the relationship between Parkinson disease and restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Mood and sleep in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Melatonin for sleep disturbances in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Nocturnal akathisia in Parkinson's disease: treatment with clozapine.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Quetiapine for insomnia in Parkinson disease: results from an open-label trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Update on the pharmacology of REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Restoration of normal motor control in Parkinson's disease during REM sleep

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Aggressive dream content without daytime aggressiveness in REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Oneiric behavior in cats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep without atonia after lesions of the medial medulla.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Localization of the GABAergic and non-GABAergic neurons projecting to the sublaterodorsal nucleus and potentially gating paradoxical sleep onset.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

A putative flip-flop switch for control of REM sleep

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Cardiac Autonomic Activity During Wakefulness and Sleep in REM Sleep Behavior Disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Slowing of electroencephalogram in rapid eye movement sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Excessive daytime sleepiness and subsequent development of Parkinson disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Predictors of sudden onset of sleep in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Excessive daytime sleepiness in parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Effect of genetically caused excess of brain gamma-hydroxybutyric acid and GABA on sleep.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

FAST TRACK: daytime sleepiness in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Hypocretin (orexin) loss in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Hypocretin (orexin) cell loss in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Brain histidine decarboxylase activity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Vigilance states in a parkinsonian model, the MPTP mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

REM sleep behavior disorder and vocal cord paralysis in Machado‐Joseph disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0775

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0775

1 reference

18 August 2017

1 reference

PubMed ID

18398415